SG Americas Securities
LEGN icon

SG Americas Securities’s Legend Biotech LEGN Stock Holding History

SG Americas Securities’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Sell
96,640
-439,018
-82% -$11.8M ﹤0.01% 1344
2026
Q1 		$9.69M Buy
535,658
+163,930
+44% +$3.13M 0.01% 800
2025
Q4 		$8.08M Buy
371,728
+366,321
+6,775% +$10.5M 0.01% 867
2025
Q3 		$176K Sell
5,407
-2,010
-27% -$74.2K ﹤0.01% 2811
2025
Q2 		$263K Sell
7,417
-117,509
-94% -$3.81M ﹤0.01% 2101
2025
Q1 		$4.24M Buy
124,926
+108,509
+661% +$3.89M 0.01% 524
2024
Q4 		$534K Buy
16,417
+12,057
+277% +$499K ﹤0.01% 1278
2024
Q3 		$212K Buy
+4,360
New +$232K ﹤0.01% 2442
2024
Q2 		– Sell
-18,854
Closed -$1.06M – 3093
2024
Q1 		$1.06M Sell
18,854
-21,179
-53% -$1.28M 0.01% 1113
2023
Q4 		$2.41M Buy
40,033
+13,381
+50% +$848K 0.02% 605
2023
Q3 		$1.79M Sell
26,652
-132,424
-83% -$9.2M 0.02% 817
2023
Q2 		$11M Buy
159,076
+2,453
+2% +$160K 0.08% 157
2023
Q1 		$7.55M Buy
156,623
+13,732
+10% +$672K 0.09% 174
2022
Q4 		$7.13M Buy
142,891
+5,266
+4% +$255K 0.09% 187
2022
Q3 		$5.62M Sell
137,625
-3,091
-2% -$145K 0.07% 240
2022
Q2 		$7.74M Sell
140,716
-13,499
-9% -$570K 0.08% 198
2022
Q1 		$5.6M Sell
154,215
-138,010
-47% -$5.45M 0.04% 368
2021
Q4 		$13.6M Buy
+292,225
New +$14.8M 0.07% 202

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

SG Americas Securities's LEGN Position: Q2 2026 in Review

SG Americas Securities reduced its Legend Biotech (LEGN) stake by 82% in Q2 2026, selling an estimated $11.8M and leaving 96,640 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1344.

SG Americas Securities first reported a position in LEGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.6M in Q4 2021. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • SG Americas Securities held 96,640 shares of Legend Biotech worth $2.79M as of Q2 2026.
  • SG Americas Securities sold 439,018 Legend Biotech shares in Q2 2026, an estimated $11.8M.
  • Legend Biotech made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1344 holding.
  • SG Americas Securities first reported a position in Legend Biotech in Q4 2021 and has held it in 18 quarters since.
  • SG Americas Securities's Legend Biotech position peaked at $13.6M in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.